Suebpong Tanasanvimon

7PUBLICATIONS
59CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Solid tumoursTraditional Chinese medicine and treatmentsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jun 01, 2026
Feasibility and Preliminary Effectiveness of the ChulaCancer Mobile Chatbot for Supportive Care of Patients With Breast or Colorectal Cancer Receiving Chemotherapy: Pilot Randomized Controlled Trial.

|May 07, 2026
The Phase Ib IMPACT Trial of Intramuscular Personalized Neoantigen Synthetic Long Peptide Vaccines in Patients with Advanced Melanoma and Renal Cell Carcinoma.

|Dec 01, 2022
Efficacy, Safety, and Patient-Reported Outcomes of Atezolizumab Plus Bevacizumab for Unresectable Hepatocellular Carcinoma in Thailand: A Multicenter Prospective Study.

Chanchai Charonpongsuntorn, Suebpong Tanasanvimon, Krittiya Korphaisarn

|Dec 30, 2021
Effects of Complementary and Alternative Medicine on Chemotherapy Delivery in Thai Patients.

Chawanya Rabiltossaporn, Ploytuangporn Wongchanapai, Nattaya Poovoravan

|Aug 26, 2021
Phase II, Randomized Study of Spartalizumab (PDR001), an Anti-PD-1 Antibody, versus Chemotherapy in Patients with Recurrent/Metastatic Nasopharyngeal Cancer.

Caroline Even, Hung-Ming Wang, Shau-Hsuan Li

|Apr 21, 2021
Clinical and Immunologic Responses to a B-Cell Epitope Vaccine in Patients with HER2/neu-Overexpressing Advanced Gastric Cancer-Results from Phase Ib Trial IMU.ACS.001.

Ursula Wiedermann, Erika Garner-Spitzer, Yee Chao

Pageof 2

Frequent Collaborators

3 joint publications

Nussara Pakvisal

2 joint publications

Nicha Zungsontiporn

2 joint publications

Virote Sriuranpong

2 joint publications

Napa Parinyanitikul